Please wait...

Learn

Finding accredited CPD

The role of triple therapy in respiratory disease: COPD

Description

Chronic Obstructive Pulmonary Disease (COPD) is a significant health issue in the Australian community, and patients often continue to experience debilitating symptoms despite standard therapy. Healthscope, in collaboration with their Respiratory Physicians, have launched a new 3.5-hour CPD activity to help you navigate this important area of respiratory medicine.

In this interactive CPD module, we’re exploring “The role of triple therapy in respiratory disease: COPD”, focusing on the multi-system impact of the condition and the evidence-based management strategies that can improve patient outcomes.


Learning Outcomes

  1. Review the incidence and prevalence of COPD in the Australian community
  2. Review the multi-system impact of COPD on patients with the condition
  3. Outline current treatment and management regimes for patients with COPD.

Details

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard. 

CPD Activity Details
Provider
Domain
Educational Activities
Type
General Learning
Activity
Course / module
CPD Hours
3h : 30m
Topic
Respiratory System Diseases, General Practice and Primary Care
Audience
Medical practitioners
Applicable CAPE Aspects
_
Effective Year

You have to log in to see the content of this module.


Provided by


Accredited by

*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)